Shopping Cart
- Remove All
- Your shopping cart is currently empty
BMS-986121, a positive allosteric modulator (PAM) of the μ opioid receptor. This compound is based on a novel chemical scaffold, introducing a new chemotype for μ receptor PAMs.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $78 | 5 days |
Description | BMS-986121, a positive allosteric modulator (PAM) of the μ opioid receptor. This compound is based on a novel chemical scaffold, introducing a new chemotype for μ receptor PAMs. |
In vitro | BMS-986121, at concentrations ranging from 1 μM to 1 mM, significantly enhances the β-arrestin recruitment response initiated by a low level of endomorphin-I (PAM-detection mode). It also markedly boosts the suppression of forskolin-induced adenylyl cyclase activity by a near-EC10 concentration (30 pM) of endomorphin-I in CHOμ cells. Furthermore, at 100 μM, BMS-986121 elevates the efficacy of endomorphin-I (fourfold), morphine (fivefold), and leu-enkephalin (sixfold) in reducing forskolin-stimulated cAMP accumulation in CHO-μ cells[1]. |
Molecular Weight | 366.22 |
Formula | C15H9Cl2N3O2S |
Cas No. | 313671-26-0 |
Relative Density. | 1.530 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.